Post-stroke pneumonia prevention by angiotensin-converting enzyme inhibitors: Results of a meta-analysis of five studies in Asians

Advances in Therapy

Volumn 29, Issue 10, 2012, Pages 900-912

  Shinohara, Yukito ^a   Origasa, Hideki ^b  

^a Federation of National Public Service Personnel Mutual Aid Associations   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Aspiration pneumonia; Imidapril; Meta analysis; Post stroke; Prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMIDAPRIL; PERINDOPRIL; PLACEBO;

AGED; ARTICLE; ASIAN; ASPIRATION PNEUMONIA; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; META ANALYSIS; OUTCOME ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; MALE; PNEUMONIA, ASPIRATION; STROKE; TREATMENT OUTCOME;

EID: 84872109321     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-012-0049-1     Document Type: Article

References (39)

1. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344:665-71.
2. Pellegrini CA, DeMeester TR, Johnson LF, Skinner DB. Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality and results of surgical therapy. Surgery. 1979;86:110 -9.
3. Loeb MB, Becker M, Eady A, Walker-Dilks C. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J Am Geriatr Soc. 2003;51:1018-22.
4. Doggett DL, Tappe KA, Mitchell MD, Chapell R, Coates V, Turkelson CM. Prevention of pneumonia in elderly stroke patients by systematic diagnosis and treatment of dysphagia: an evidence-based comprehensive analysis of the literature. Dysphagia. 2001;16:279-95.
5. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620-5.
6. Kimura K, Minematsu K, Kazui S, Yamaguchi T; the Japan Multicenter Stroke Investigators' Collaboration (J-MUSIC). Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc Dis. 2005;19:171-8.
7. Nakagawa T, Wada H, Sekizawa K, Arai H, Sasaki H. Amantadine and pneumonia. Lancet. 1999;353:1157.
8. Yamaya M, Yanai M, Ohrui T, Arai H, Sekizawa K, Sasaki H. Antithrombotic therapy for prevention of pneumonia. J Am Geriatr Soc. 2001;49:687-8.
9. Shinohara Y; the CSPS Group. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. Cerebrovasc Dis. 2006;22:57-60.
10. Arai T, Yoshimi N, Fujiwara H, Fujiwara H, Sekizawa K. Serum substance P concentrations and silent aspiration in elderly patients with stroke. Neurology. 2003;61:1625-6.
11. Sekizawa K, Matsui T, Nakagawa T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet. 1998;352:1069.
12. Ohkubo T, Chapman N, Neal B, et al; the Perindopril Protection Against Recurrent Stroke Study Collaborative Group. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med. 2004;169:1041-5.
13. Arai T, Yasuda Y, Toshima S, Yoshimi N, Kashiki Y. ACE inhibitors and pneumonia in elderly people. Lancet. 1998;352:1937-8.
14. Teramoto S. Novel preventive and therapeutic strategy for post-stroke pneumonia. Expert Rev Neurother. 2009;9:1187-200.
15. Arai T, Yasuda Y, Takaya T, et al. ACE inhibitors and reduction of the risk of pneumonia in elderly people. Am J Hypertens. 2000;13:1050-1.
16. Arai T, Yasuda Y, Takaya T, et al. Angiotensin-converting enzyme inhibitor, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke. Chest. 2001;119:660-1.
17. Akutagawa O, Honda K, Sasaki T. A study of prevention of pneumonia development in the elderly by ACE inhibitors. Progr Med. 2002;22:2705-8. In Japanese.
18. Arai T, Sekizawa K, Ohrui T, et al. ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology. 2005;64:573-4.
19. Bender R. Calculating confidence intervals for the number needed to treat. Control Clin Trials. 2001;22:102-10.
20. Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications after acute stroke. Stroke. 1996;27:415-20.
21. Scottish Intercollegiate Guidelines Network. Management of patients with stroke: Identification and management of dysphagia. A national clinical guideline. Edinburgh: Elliott House; 2010.
22. MacMahon S, Collins R. Reliable assessment of the effects of treatment on mortality and major morbidity, II: Observational studies. Lancet. 2001;357:455-62.
23. Van de Garde EMW, Souverein PC, Hak E, Deneer VH, van den Bosch JM, Leufkens HG. Angiotensinconverting enzyme inhibitor use and protection against pneumonia in patients with diabetes. J Hypertens. 2007;25:235-9.
24. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: A review of the literature and pathophysiology. Ann Intern Med. 1992;117:234-42.
25. Nakayama K, Sekizawa K, Sasaki H. ACE inhibitor and swallowing reflex. Chest. 1998;113:1425.
26. Itoh M, Meguro K, Fujiwara T, et al. Assessment of dopamine metabolism in brain of patients with dementia by means of 18F-fluorodopa and PET. Ann Nucl Med. 1994;8:245-51.
27. Yamaya M, Yanai M, Ohrui T, Arai H, Sasaki H. Interventions to prevent pneumonia among older adults. J Am Geriatr Soc. 2001;49:85-90.
28. Nakagawa T, Ohrui T, Sekizawa K, Sasaki H. Sputum substance P in aspiration pneumonia. Lancet. 1995;345:1447.
29. Cascieri MA, Bull HG, Mumford RA, Patchett AA, Thornberry NA, Liang T. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422. Mol Pharmacol. 1984;25:287-93.
30. Shore SA, Stimler-Gerard NP, Coats SR, Drazen JM. Substance P-induced bronchoconstriction in the guinea pig. Enhancement by inhibitors of neutral metalloendopeptidase and angiotensin-converting enzyme. Am Rev Respir Dis. 1988;137:331-6.
31. Sekizawa K, Jia YX, Ebihara T, Hirose Y, Hirayama Y, Sasaki H. Role of substance P in cough. Pulm Pharmacol. 1996;9:323-8.
32. Medhora M, Gao F, Jacobs ER, Moulder JE. Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology. 2012;17:66-71.
33. Woo J, Chan TYK. A high incidence of cough associated with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects. Br J Clin Pract. 1991;45:178-80.
34. Chan WK, Chan TYK, Luk WK, Leung VK, Li TH, Critchley JA. A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol. 1993;44:299-300.
35. Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol. 1995;40:141-4.
36. Sharpe N; the international HOPE TIPS investigators. The HOPE TIPS: the HOPE study translated into practices. Cardiovasc Drugs Ther. 2005;19:197-201.
37. Morimoto S, Okaishi K, Onishi M, et al. Deletion allele of the angiotensin-converting enzyme gene as a risk factor for pneumonia in elderly patients. Am J Med. 2002;112:89-94.
38. Saruta T, Omae T, Kuramochi M, et al. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control. J Hypertens. 1995;13(Suppl. 3):S23-S30.
39. Ebihara T, Sekizawa K, Nakazawa H, Sasaki H. Capsaicin and swallowing reflex. Lancet. 1993;341:432.